Clinical Trial Update: Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TL117 in recurrent or metastatic head and neck squamous cell carcinoma (Phase 1/Phase 2); the study is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• TL117

Snippet

Sponsor: Suzhou Junde Biotechnology Co., Ltd | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING